• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    S&P Spin-Off Invesco ETF (NY: CSD )

    82.83 -0.64 (-0.77%)
    Official Closing Price Updated: 8:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about S&P Spin-Off Invesco ETF

    Kyndryl, Dell, Nvidia Join Forces To Launch AI Private Cloud For Japanese Enterprises
    Kyndryl Holdings shares are trading higher after the company launched a dedicated AI private cloud in Japan. 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
    GE HealthCare and DeepHealth collaborate to develop AI-powered solutions for imaging, starting with breast cancer screening. 
    Via Benzinga
    GE Vernova Gains Investor Confidence With Strong Revenue Outlook And Path To Higher Margins, Say Analysts
    GEV share price rises on strong earnings, with analysts optimistic about future revenue and margins. Morgan Stanley raises PT to $301, RBC raises PT to $285, and Oppenheimer remains cautious. 
    Via Benzinga
    GE Vernova Set For $2.5B Free Cash Flow By 2026 Amid Energy Transition Boom, Bullish Analyst Says
    Analyst initiates coverage on GEV with Buy rating and $300 price target, citing strong position in energy transition and growth potential. 
    Via Benzinga
    GE Vernova's Gas Power Services Underappreciated & Poised For Growth: Analyst
    GE Vernova upgraded to Buy by BofA Securities, price target raised from $200 to $300. Analyst sees potential in Gas Power Services. 
    Via Benzinga
    GXO Logistics Q2: Revenue Gains Offset By Profit Margin Squeeze
    GXO Logistics beats revenue consensus with $2.85B in Q2. Organic revenue rose 2%, new business wins add $270M. FY24 outlook reaffirmed. 
    Via Benzinga
    GE HealthCare Taps AWS for Groundbreaking AI Medical Solutions: Details
    GEHC and AWS partner to advance healthcare through specialized foundation models and generative AI apps, using AWS' cloud and AI services. 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    What's Going On With GE Vernova Shares Today?
    GE Vernova has secured a major order from Sonelgaz through their joint venture, GE Algeria Turbines, to enhance Algeria's grid infrastructure. 
    Via Benzinga
    GXO Logistics Deploys Robotics Solution For Sporting Goods Retailer In France
    GXO Logistics implements robotics solution for a global sporting goods retailer in France, streamlining order processing and enhancing adaptability in logistics. 
    Via Benzinga
    Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
    Invest smarter with Wall Street's exchange-traded funds and seize market momentum with these thematic ETFs to buy. 
    Via InvestorPlace
    Topics ETFs
    Why Carrier Global Shares Are Surging Today
    Carrier Global shares are trading higher on Q1 FY24 results, with net sales and adjusted EPS beating consensus. Company also revises sales outlook and expects to resume share repurchases in 2024. 
    Via Benzinga
    Why Apartment Income REIT Shares Are Rocketing Today
    Blackstone is acquiring Apartment Income REIT Corp. for $10 billion. The deal will take AIR Communities private and suspend dividends. 
    Via Benzinga
    Radiopharmaceuticals Startup RayzeBio Seeks Public Debut After Raising $400M From Investors
    RayzeBio Inc, a San Diego company focused on radiopharmaceutical therapies for cancer, filed on Thursday to raise up to $1 
    Via Benzinga
    Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation
    Waystar Inc, a provider of financial management software for hospitals and medical practices, is reportedly making strides toward an initial public offering (IPO) that could value the company up to $8... 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    Second Time Charm: Sagimet Biosciences Seeks Public Debut With $75M IPO
    On Friday, Sagimet Biosciences, a clinical-stage biopharmaceutical company, filed with the SEC to raise up to $75 million in an initial public off 
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.